Why is Matt Holt making a $30B bet on simplified health tech?

Matt Holt, former New Mountain Capital executive, is exploring a $30 billion deal to combine five health tech startups into a single platform called Thoreau. The venture would set out to simplify and integrate services across payers, providers and data — and if completed, it would rank among the largest private equity-backed health tech companies ever. Time will tell if this massive consolidation ever gets completed or translates into real value — or if it's just another bet on scale.

Editor's Pick

Top Story Less Is More: Why Matt Holt Is Making a $30B Bet on Simplified Health Tech Matt Holt, former New Mountain Capital executive, is exploring a $30 billion deal to combine five health tech startups into a single platform called Thoreau. The venture would set out to simplify and integrate services across payers, providers and data — and if completed, it would rank among the largest private equity-backed health tech companies ever. Time will tell if this massive consolidation ever gets completed or translates into real value — or if it's just another bet on scale. Sponsored Esperion Sets Its Sights on New Areas While Maintaining Commitment to Cardiovascular Health Presented by Esperion Heart disease remains the leading cause of death in the US and worldwide—for both men and women. Esperion is offering a variety of educational tools for both healthcare providers and patients to raise awareness about statin intolerance and alternative treatments.  Learn More

Featured News

What Health Experts Are Saying About the MAHA ELEVATE Program CMS has introduced the MAHA ELEVATE model to expand lifestyle medicine in Medicare, a move experts support but say will hinge on effective implementation. Startup Alveus Therapeutics Emerges With $160M to Shape the Future of Obesity Drugs Alveus Therapeutics' Phase 2-ready lead drug hits the same two targets as Amgen's MariTide, but with the potential for a dosing advantage. The startup's pipeline also includes molecules that could compete with drugs in development by Roche and Novo Nordisk. Eli Lilly Boosts Its Immunology Drug Pipeline With $1.2B Ventyx Bio Acquisition Ventyx Biosciences' lead program, an oral small molecule inhibitor of NLRP3, has encouraging clinical data from separate mid-stage tests in cardiovascular disease and Parkinson's disease. Eli Lilly said Ventyx's pipeline has potential applications in cardiometabolic health, neurodegeneration, and autoimmunity. Pharma's Make-or-Break Moment: How AI Is Rewriting the Rules of Customer Engagement Those who act first will lower cost to serve, boost rep productivity and deliver customer experiences that feel personal, not programmatic. Those who wait risk falling behind as competitors turn engagement into a true differentiator. AI Decides Who Gets Care: Tackling Bias in AI Coverage Decisions While there is a significant need and opportunity to address this overall spend with advanced AI tools that predict patient needs and readmission likelihood, intrinsic biases within these algorithms ultimately cause more harm than good and financial savings are being achieved at the expense of patient's health.

Video   How Samsung is tackling ultrasound user variability Samsung Healthcare's new ultrasound system is seeking to improve image quality by tackling the user variability problem.

Sponsored How and Where to Apply for a Covered California Health Insurance Plan Presented by Health for California The marketplace allows you to compare standardized plans, access subsidies and enroll with confidence. Using a certified enrollment partner, such as Health for California, ensures that your application is accurate, supported and submitted through an authorized channel. Learn More

Resources

MedCity FemFwd: The Importance of Virtual Maternal-Fetal Medicine In this episode, we're joined by Dr. Blake Porter, chief of maternal-fetal medicine with Access TeleCare. He discusses the need to expand access to virtual maternal-fetal medicine care. View Now

MedCity News • PO Box 901 • New York, NY unsubscribe